Search

for
Search:

Sort by

Research

990-1000 / 1000+ results

Study of Human Leukocyte Antigen in 13 Cases of Familial Frontal Fibrosing Alopecia: CYP21A2 Gene p.V281L Mutation from Congenital Adrenal Hyperplasia Linked to HLA Class I Haplotype HLA-A*33:01; B*14:02; C*08:02 as a Genetic Marker

research Study of Human Leukocyte Antigen ( HLA ) in 13 cases of familial frontal fibrosing alopecia: CYP 21A2 gene p.V281L mutation from congenital adrenal hyperplasia linked to HLA class I haplotype HLA ‐ A33:01 ; B14:02; C*08:02 as a genetic marker

7 citations , January 2019 in “Australasian Journal of Dermatology”

A genetic marker linked to a type of hair loss was found in most patients studied.

research Research on Mental Stress Recognition of Depressive Disorders in Patients With Androgenic Alopecia Based on Machine Learning and Fuzzy K-Means Clustering

November 2021 in “Frontiers in Genetics”

The FAW-FS algorithm improves depression recognition, and psychological interventions help AGA patients' mental health.

research Epigallocatechin-3 Gallate Inhibits STAT-1/JAK2/IRF-1/HLA-DR/HLA-B and Reduces CD8 MKG2D Lymphocytes of Alopecia Areata Patients

15 citations , December 2018 in “International journal of environmental research and public health/International journal of environmental research and public health”

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

research JAK1 Signaling Is Involved in the Induction of Mechanical Alloknesis in Atopic Dermatitis

November 2025 in “Biomedicines”

JAK1 inhibitors can help reduce itchiness in atopic dermatitis.

research PD02-05 SRD5A2 EXPRESSION IS A PREDICTOR OF RESPONSE TO FINASTERIDE IN THE MTOPS TRIAL

March 2023 in “The Journal of Urology”

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

Diphencyprone and Topical Tacrolimus as Two Topical Immunotherapeutic Modalities: Are They Effective in the Treatment of Alopecia Areata Among Egyptian Patients? A Study Using CD4, CD8, and MHC II as Markers

research Diphencyprone and topical tacrolimus as two topical immunotherapeutic modalities. Are they effective in the treatment of alopecia areata among Egyptian patients? A study using CD4, CD8 and MHC II as markers

13 citations , June 2010 in “Journal of dermatological treatment”

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

research Tru9I Variant as a Novel Genetic Marker for Vitamin D Deficiency in Alopecia Areata

March 2025 in “Clinical Cosmetic and Investigational Dermatology”

The Tru9I variant in the VDR gene may influence alopecia areata risk and vitamin D levels.

IL-15 Prolongs Hair Growth and Acts as a Guardian of Human Hair Follicle Immune Privilege

research 056 IL-15 prolongs hair growth and operates as a guardian of human hair follicle immune privilege

July 2022 in “Journal of Investigative Dermatology”

IL-15 helps maintain hair growth and protects the immune status of hair follicles.

research Elevation of circulating DNAs of disease-associated cytokines in serum cell-free DNA from patients with alopecia areata

April 2024 in “Bioscience trends”

Higher levels of certain DNAs in blood may indicate hair follicle damage in alopecia areata patients.

research Peppermint oil modulating TGF-β1/VEGF pathways to reduce androgenic alopecia in male albino mice

January 2026 in “AIP conference proceedings”

← Previous page